Advanced and Integrative Therapeutic Strategies in Parkinson's Disease Management

Advanced and Integrative Therapeutic Strategies in Parkinson’s Disease Management offers a comprehensive exploration of the latest innovations and multidisciplinary approaches in Parkinson’s Disease treatment. The volume is organized into sections covering genetic therapies, gut microbiota, artificial intelligence, virtual reality, neuroprotective strategies, polypharmacy, and combination therapies. It addresses the integration of personalized medicine, neuroprotective diets, natural products, cognitive enhancers, and ethical considerations. Additional chapters introduce traditional medicine, music therapy, and the synergy between pharmacotherapy and complementary modalities. The book equips readers with the knowledge to implement innovative therapies, navigate complex ethical landscapes, and integrate multidisciplinary and complementary approaches.

This reference is essential for those seeking to advance clinical practice and research in Parkinson’s Disease through the adoption of cutting-edge strategies.

Section I: Advanced & Precision Therapies
1. Genetic Therapies for Parkinson’s Disease: The Dawn of Precision Medicine
2. Role of Gut Microbiota in Parkinson’s Disease Pharmacotherapy
3. Artificial Intelligence, Machine Learning, Virtual Reality & Gamification in Drug Development
4. rTMS as an Adjunct to Pharmacotherapy
5. Neuroprotective Therapies
6. Polypharmacy and Combination Therapies

Section II: Integration, Cognition & Future Horizons
7. Repurposing Existing Drugs for Parkinson’s Disease Management
8. Personalized Medicine in Parkinson’s Disease
9. Neuroprotective Diets & Synergy with Pharmacotherapy
10. Natural Products in Parkinson’s Disease Animal Models
11. Cognitive Enhancers in Parkinson’s Disease
12. Emerging Targets for Cognitive Enhancement
13. Ethical & Practical Challenges with Cognitive Enhancers
14. Unani Pharmacotherapy in Parkinson’s Disease
15. Music Therapy & Its Synergy with Pharmacotherapy

Authors

Wael Mohamed Neuroscientist and Pharmacologist, Kulliyyah of Medicine, International Islamic University Malaysia; Founder and Chair, AfrAbia PD Genomic Consortium, Malaysia. Dr. Wael Mohamed Yousef Mohamed is Professor of Basic Medical Science at the International Islamic University Malaysia, with over 20 years of experience in translational brain research and longevity science. He earned his MD and MSc in Clinical Pharmacology from Meoufia Medical School, Egypt, and his PhD in Neuroscience from The Pennsylvania State University. His research focuses on aging-related neurodegeneration, particularly Alzheimer's and Parkinson's diseases, aiming to understand the biological mechanisms of aging and develop therapies to extend healthspan. Dr. Mohamed investigates how aging influences neurodegenerative processes and seeks targeted interventions to promote healthy longevity. He is a member of leading neuroscience societies, including the Society for Neuroscience. His prior editorial work with Elsevier includes titles on neurodegenerative and movement disorders, reflecting his expertise in aging, neurodegeneration, and longevity.

Table of Contents

Authors

Related Topics

Related Products

Pharmacological Foundations of Parkinson's Disease. From Mechanisms to Clinical Practice

Translational Models of Parkinson's Disease and related Movement Disorders

Essential Guide to Neurodegenerative Disorders. Mechanistic, Diagnostic and Therapeutic Advances

Nutrition and Neurological Disorders

A Review on Diverse Neurological Disorders. Pathophysiology, Molecular Mechanisms, and Therapeutics